Ming-Li Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ming-Li Wang has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Jun Zhao
Anhui Med Univ, Dept Microbiol, Hefei 230032, Anhui, Peoples R China
13 shared publications Lin Gan
Department of Microbiology, Anhui Medical University, Hefei, Anhui Province, China
8 shared publicationsJason Chen
Department of Microbiology, Anhui Medical University, Hefei, Anhui Province, China
7 shared publicationsYu Zhao
Anhui JiuChuan Biotech Co., Ltd., Wuhu, Anhui Province, China
6 shared publicationsHai-Yang Yu
Department of Microbiology, Anhui Medical University, Hefei, Anhui Province, 230032, PR China
5 shared publications- Hai-Yang Yu
Department of Microbiology, Anhui Medical University, Hefei, Anhui Province, 230032, China
5 shared publications
Latest Publications
- 1 January 2021
- Published by Elsevier in Veterinary Microbiology
- Vol. 252, 108930
Inhibitory effects of recombinant porcine interferon-α on porcine transmissible gastroenteritis virus infections in TGEV-seronegative piglets
- 1 January 2021
- Published by Elsevier in Veterinary Microbiology
- Vol. 252, 108930
Inhibitory effects of recombinant porcine interferon-α on porcine transmissible gastroenteritis virus infections in TGEV-seronegative piglets
- 30 March 2020
- Published by Pleiades Publishing Ltd in Applied Biochemistry and Microbiology
- Vol. 56 (2) , 154-163
Soluble Expression, Rapid Purification and Antiviral Activity of Recimbinant Bovine Interferon-α in Escherichia coli
In this study, the cDNA of mature bovine interferon-α (BoIFN-α) gene was cloned and expressed in the Escherichia coli expression system. Total RNA was extracted from bovine liver cells and reverse transcribed into cDNA, and then BoIFN-α gene fragment was amplified with specific primers by PCR method before being ligated into the pET-32a (+) expression vector. Since the pET-32a (+) plasmid expresses the thioredoxin A (TrxA) tag protein, it can increase the solubility of the target protein. In order to express the target protein, the pET-32a-BoIFN-α recombinant plasmid was transformed into E. coli Rosetta (DE3) strain followed by IPTG induction. It was found that the recombinant fusion protein Trx-rBoIFN-α was finally expressed in a soluble form in the host cell, accounting for about 33.45% of the total cellular protein. The protein was purified by two-step chromatography, including Ni2+-chelating Sepharose affinity chromatography and DEAE anion exchange chromatography. The purity of the purified product reached 93.0%, and the cytopathic effects (CPE) inhibition method was adopted to determine the antiviral activity of the expressed fusion protein in vesicular stomatitis virus/ Madin-Darby bovine kidney cells titration system. The specific activity of the recombinant fusion protein Trx-rBoIFN-α was measured as (3.6 ± 0.25) × 106 U/mg. After cutting of the Trx tag protein by enterokinase digestion, the remaining solo protein was confirmed as rBoIFN-α protein by Western blot assay. These findings will enable us to produce a large number of bioactive rBoIFN-α protein for future application.
- 30 March 2020
- Published by Pleiades Publishing Ltd in Applied Biochemistry and Microbiology
- Vol. 56 (2) , 154-163
Soluble Expression, Rapid Purification and Antiviral Activity of Recimbinant Bovine Interferon-α in Escherichia coli
In this study, the cDNA of mature bovine interferon-α (BoIFN-α) gene was cloned and expressed in the Escherichia coli expression system. Total RNA was extracted from bovine liver cells and reverse transcribed into cDNA, and then BoIFN-α gene fragment was amplified with specific primers by PCR method before being ligated into the pET-32a (+) expression vector. Since the pET-32a (+) plasmid expresses the thioredoxin A (TrxA) tag protein, it can increase the solubility of the target protein. In order to express the target protein, the pET-32a-BoIFN-α recombinant plasmid was transformed into E. coli Rosetta (DE3) strain followed by IPTG induction. It was found that the recombinant fusion protein Trx-rBoIFN-α was finally expressed in a soluble form in the host cell, accounting for about 33.45% of the total cellular protein. The protein was purified by two-step chromatography, including Ni2+-chelating Sepharose affinity chromatography and DEAE anion exchange chromatography. The purity of the purified product reached 93.0%, and the cytopathic effects (CPE) inhibition method was adopted to determine the antiviral activity of the expressed fusion protein in vesicular stomatitis virus/ Madin-Darby bovine kidney cells titration system. The specific activity of the recombinant fusion protein Trx-rBoIFN-α was measured as (3.6 ± 0.25) × 106 U/mg. After cutting of the Trx tag protein by enterokinase digestion, the remaining solo protein was confirmed as rBoIFN-α protein by Western blot assay. These findings will enable us to produce a large number of bioactive rBoIFN-α protein for future application.
- 7 November 2019
- Published by SAGE Publications in Viral Immunology
- Vol. 32 (9) , 383-392
Recombinant Porcine Interferon Alpha Enhances Immune Responses to Killed Porcine Reproductive and Respiratory Syndrome Virus Vaccine in Pigs
In this study, the immunoadjuvant effects of recombinant porcine interferon alpha (rPoIFN α ) on the killed virus vaccine (KV) of porcine reproductive and respiratory syndrome virus (PRRSV) in pigs were investigated. The experimental pigs were divided into six groups, including normal control group, rPoIFN α control group, PRRSV KV control group, KV+40,000 U rPoIFN α immunization group, KV+400,000 U rPoIFN α immunization group, and KV+4,000,000 U rPoIFN α immunization group. The experimental pigs were boosted immunized on the 28th day after the initial immunization, and the heparinized blood and serum samples were collected at different time points of these two immunizations to detect and evaluate the immune responses of pigs after immunization by ELISA assay, neutralization assay, flow cytometry, and so on. The results showed that the proportion of the levels of PRRSV-specific antibodies, neutralizing antibodies, stimulation index, IL-4, IFN-γ, and lymphocytes within the groups immunized with KV+rPoIFN α were significantly higher than that group immunized with KV alone. The humoral and cellular immune responses in pigs were markedly enhanced by rPoIFN α after the coadministration with KV vaccine. Therefore, we tentatively think that rPoIFN α is a potential immune promoter with prospects for future applications in the pig industry.
- 7 November 2019
- Published by SAGE Publications in Viral Immunology
- Vol. 32 (9) , 383-392
Recombinant Porcine Interferon Alpha Enhances Immune Responses to Killed Porcine Reproductive and Respiratory Syndrome Virus Vaccine in Pigs
In this study, the immunoadjuvant effects of recombinant porcine interferon alpha (rPoIFN α ) on the killed virus vaccine (KV) of porcine reproductive and respiratory syndrome virus (PRRSV) in pigs were investigated. The experimental pigs were divided into six groups, including normal control group, rPoIFN α control group, PRRSV KV control group, KV+40,000 U rPoIFN α immunization group, KV+400,000 U rPoIFN α immunization group, and KV+4,000,000 U rPoIFN α immunization group. The experimental pigs were boosted immunized on the 28th day after the initial immunization, and the heparinized blood and serum samples were collected at different time points of these two immunizations to detect and evaluate the immune responses of pigs after immunization by ELISA assay, neutralization assay, flow cytometry, and so on. The results showed that the proportion of the levels of PRRSV-specific antibodies, neutralizing antibodies, stimulation index, IL-4, IFN-γ, and lymphocytes within the groups immunized with KV+rPoIFN α were significantly higher than that group immunized with KV alone. The humoral and cellular immune responses in pigs were markedly enhanced by rPoIFN α after the coadministration with KV vaccine. Therefore, we tentatively think that rPoIFN α is a potential immune promoter with prospects for future applications in the pig industry.
- 1 July 2019
- Published by Elsevier in Veterinary Microbiology
- Vol. 234, 77-82
Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken
- 1 July 2019
- Published by Elsevier in Veterinary Microbiology
- Vol. 234, 77-82
Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken
- 7 February 2019
- Published by Taylor & Francis in Preparative Biochemistry & Biotechnology
- Vol. 49 (2) , 192-201
Soluble expression, rapid purification, biological identification of chicken interferon-alpha using a thioredoxin fusion system in E. coli and its antiviral effects to H9N2 avian influenza virus
In this paper, we report a soluble expression based on Escherichia coli and two-step purification of a novel thioredoxin-tagged chicken interferon-α fusion protein (Trx-rChIFN-α) by using pET32a(+) expression system. The mature ChIFN-α gene was amplified by Reverse transcriptase-polymerase chain reaction (RT-PCR) and subcloned into pET-32a (+) vector prior to transformation into Rosetta (DE3) competent cells. After IPTG induction, the recombinant fusion protein was expressed efficiently in the soluble fraction. The protein purification was performed by nickel affinity chromatography and DEAE anion exchange chromatography. The purified product has a purity of 95% with a yield of 47.3 mg/L of culture. The specific activity of the fusion protein reaches to 2.0 × 107 IU/mg as determined in the CEF/VSV titration system. After excision of the Trx tag by enterokinase, the remaining solo protein was confirmed as rChIFN-α protein by SDS-PAGE, N-terminal sequencing and mass spectrometry. The effects of this Trx-rChIFN-α fusion protein against H9N2 influenza virus infection were also evaluated in ovo. The results showed that the Trx-rChIFN-α protein could significantly reduce the hemagglutination titer of H9N2 virus, and the H9N2 viruses HA gene copy numbers. These findings will enable us to produce large amount and bio-active rChIFN-α protein for future applications.
- 7 February 2019
- Published by Taylor & Francis in Preparative Biochemistry & Biotechnology
- Vol. 49 (2) , 192-201
Soluble expression, rapid purification, biological identification of chicken interferon-alpha using a thioredoxin fusion system in E. coli and its antiviral effects to H9N2 avian influenza virus
In this paper, we report a soluble expression based on Escherichia coli and two-step purification of a novel thioredoxin-tagged chicken interferon-α fusion protein (Trx-rChIFN-α) by using pET32a(+) expression system. The mature ChIFN-α gene was amplified by Reverse transcriptase-polymerase chain reaction (RT-PCR) and subcloned into pET-32a (+) vector prior to transformation into Rosetta (DE3) competent cells. After IPTG induction, the recombinant fusion protein was expressed efficiently in the soluble fraction. The protein purification was performed by nickel affinity chromatography and DEAE anion exchange chromatography. The purified product has a purity of 95% with a yield of 47.3 mg/L of culture. The specific activity of the fusion protein reaches to 2.0 × 107 IU/mg as determined in the CEF/VSV titration system. After excision of the Trx tag by enterokinase, the remaining solo protein was confirmed as rChIFN-α protein by SDS-PAGE, N-terminal sequencing and mass spectrometry. The effects of this Trx-rChIFN-α fusion protein against H9N2 influenza virus infection were also evaluated in ovo. The results showed that the Trx-rChIFN-α protein could significantly reduce the hemagglutination titer of H9N2 virus, and the H9N2 viruses HA gene copy numbers. These findings will enable us to produce large amount and bio-active rChIFN-α protein for future applications.
- Open Access
Crosstalk between Autophagy and Type I Interferon Responses in Innate Antiviral Immunity
Autophagy exhibits dual effects during viral infections, promoting the clearance of viral components and activating the immune system to produce antiviral cytokines. However, some viruses impair immune defenses by collaborating with autophagy. Mounting evidence suggests that the interaction between autophagy and innate immunity is critical to understanding the contradictory roles of autophagy. Type I interferon (IFN-I) is a crucial antiviral factor, and studies have indicated that autophagy affects IFN-I responses by regulating IFN-I and its receptors expression. Similarly, IFN-I and interferon-stimulated gene (ISG) products can harness autophagy to regulate antiviral immunity. Crosstalk between autophagy and IFN-I responses could be a vital aspect of the molecular mechanisms involving autophagy in innate antiviral immunity. This review briefly summarizes the approaches by which autophagy regulates antiviral IFN-I responses and highlights the recent advances on the mechanisms by which IFN-I and ISG products employ autophagy against viruses.
Open AccessCrosstalk between Autophagy and Type I Interferon Responses in Innate Antiviral Immunity
Autophagy exhibits dual effects during viral infections, promoting the clearance of viral components and activating the immune system to produce antiviral cytokines. However, some viruses impair immune defenses by collaborating with autophagy. Mounting evidence suggests that the interaction between autophagy and innate immunity is critical to understanding the contradictory roles of autophagy. Type I interferon (IFN-I) is a crucial antiviral factor, and studies have indicated that autophagy affects IFN-I responses by regulating IFN-I and its receptors expression. Similarly, IFN-I and interferon-stimulated gene (ISG) products can harness autophagy to regulate antiviral immunity. Crosstalk between autophagy and IFN-I responses could be a vital aspect of the molecular mechanisms involving autophagy in innate antiviral immunity. This review briefly summarizes the approaches by which autophagy regulates antiviral IFN-I responses and highlights the recent advances on the mechanisms by which IFN-I and ISG products employ autophagy against viruses.
- 21 November 2018
- Published by Polish Academy of Sciences Chancellery in Polish Journal of Veterinary Sciences
- Vol. 22 (1) , 75-82
Pharmacokinetics of the recombinant ovine interferon-tau in lambs
In the current study, twenty lambs, aged 4 months, half male and half female, were classified into four groups, with five in each group. The experimental three groups of lambs were given intravenous (IV), intramuscular (IM) and subcutaneous (SC) administrations of recombinant ovine interferon-tau (roIFN-tau). The fourth group (normal control) of lambs was given normal saline injections in the same way. After administrations, blood samples were collected from the tested animals at different time points post injection, and the serum titers of roIFN-tau were measured using cytopathic effect (CPE) inhibition bioassay. The results of calculating pharmacokinetic (PK) parameters using DAS software showed that the PK characteristics of roIFN-tau through IV injection conformed to the two-compartment open model, whose half-life of distribution phases (T-1/2 alpha) was 0.33 +/- 0.034 h and the elimination half-life(T-1/2 beta) was 5.01 +/- 0.24 h. However, the PK features of IM injection and SC injection of roIFN-tau conformed to the one compartment open model, whose T-max were 3.11 +/- 0.26 h and 4.83 +/- 0.43 h, respectively, together with an elimination half life(T-1/2 beta) of 9.11 +/- 0.76h and 7.43 +/- 0.58 h, and an absorption half-life (T-1/2k(a)) of 1.13 +/- 0.31 h and 1.85 +/- 0.40 h, respectively. The bioavailability of roIFN-tau after IM administration reaches 73.57%, which is greater than that of SC administration (53.43%). These results indicate that the drug administration effect can be preferably obtained following a single dose IM administration of the roIFN-tau aqueous preparation. This study will facilitate the clinical application of roIFN-tau as a potential antiviral agent in future work.
- 21 November 2018
- Published by Polish Academy of Sciences Chancellery in Polish Journal of Veterinary Sciences
- Vol. 22 (1) , 75-82
Pharmacokinetics of the recombinant ovine interferon-tau in lambs
In the current study, twenty lambs, aged 4 months, half male and half female, were classified into four groups, with five in each group. The experimental three groups of lambs were given intravenous (IV), intramuscular (IM) and subcutaneous (SC) administrations of recombinant ovine interferon-tau (roIFN-tau). The fourth group (normal control) of lambs was given normal saline injections in the same way. After administrations, blood samples were collected from the tested animals at different time points post injection, and the serum titers of roIFN-tau were measured using cytopathic effect (CPE) inhibition bioassay. The results of calculating pharmacokinetic (PK) parameters using DAS software showed that the PK characteristics of roIFN-tau through IV injection conformed to the two-compartment open model, whose half-life of distribution phases (T-1/2 alpha) was 0.33 +/- 0.034 h and the elimination half-life(T-1/2 beta) was 5.01 +/- 0.24 h. However, the PK features of IM injection and SC injection of roIFN-tau conformed to the one compartment open model, whose T-max were 3.11 +/- 0.26 h and 4.83 +/- 0.43 h, respectively, together with an elimination half life(T-1/2 beta) of 9.11 +/- 0.76h and 7.43 +/- 0.58 h, and an absorption half-life (T-1/2k(a)) of 1.13 +/- 0.31 h and 1.85 +/- 0.40 h, respectively. The bioavailability of roIFN-tau after IM administration reaches 73.57%, which is greater than that of SC administration (53.43%). These results indicate that the drug administration effect can be preferably obtained following a single dose IM administration of the roIFN-tau aqueous preparation. This study will facilitate the clinical application of roIFN-tau as a potential antiviral agent in future work.
- 1 January 2018
- Published by Kafkas University in Kafkas Universitesi Veteriner Fakultesi Dergisi
- Vol. 25 (1) , 17-23
Sığırlarda Rekombinant Bovine İnterferon-alfa Üzerine Farmakokinetik Çalışmalar
- 1 January 2018
- Published by Kafkas University in Kafkas Universitesi Veteriner Fakultesi Dergisi
- Vol. 25 (1) , 17-23
Sığırlarda Rekombinant Bovine İnterferon-alfa Üzerine Farmakokinetik Çalışmalar